Global Therapeutic Vaccines Market Insights and Forecast to 2026

Published On: Sep 2020

Format: PDF

Publisher: QY Research

Pages: 116

Report ID: 236254

Therapeutic Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Therapeutic Vaccines market is segmented into
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine

Segment by Application, the Therapeutic Vaccines market is segmented into
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others

Regional and Country-level Analysis
The Therapeutic Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Therapeutic Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Therapeutic Vaccines Market Share Analysis
Therapeutic Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Vaccines business, the date to enter into the Therapeutic Vaccines market, Therapeutic Vaccines product introduction, recent developments, etc.

The major vendors covered:
Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
...

1 Study Coverage
1.1 Therapeutic Vaccines Product Introduction
1.2 Market Segments
1.3 Key Therapeutic Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Therapeutic Vaccines Market Size Growth Rate by Type
1.4.2 Peptide Therapeutic Vaccine
1.4.3 Cell Therapeutic Vaccine
1.4.4 Nucleic Acid Therapeutic Vaccine
1.5 Market by Application
1.5.1 Global Therapeutic Vaccines Market Size Growth Rate by Application
1.5.2 Oncotherapy
1.5.3 Hepatitis B
1.5.4 Tuberculosis
1.5.5 Herpes Simplex Virus
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Therapeutic Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Therapeutic Vaccines Revenue 2015-2026
2.1.2 Global Therapeutic Vaccines Sales 2015-2026
2.2 Global Therapeutic Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Therapeutic Vaccines Competitor Landscape by Players
3.1 Therapeutic Vaccines Sales by Manufacturers
3.1.1 Therapeutic Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Therapeutic Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Therapeutic Vaccines Revenue by Manufacturers
3.2.1 Therapeutic Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Therapeutic Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Therapeutic Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Therapeutic Vaccines Revenue in 2019
3.2.5 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Therapeutic Vaccines Price by Manufacturers
3.4 Therapeutic Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Therapeutic Vaccines Market Size by Type (2015-2020)
4.1.1 Global Therapeutic Vaccines Sales by Type (2015-2020)
4.1.2 Global Therapeutic Vaccines Revenue by Type (2015-2020)
4.1.3 Therapeutic Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Therapeutic Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Therapeutic Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Therapeutic Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Therapeutic Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Therapeutic Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Therapeutic Vaccines Market Size by Application (2015-2020)
5.1.1 Global Therapeutic Vaccines Sales by Application (2015-2020)
5.1.2 Global Therapeutic Vaccines Revenue by Application (2015-2020)
5.1.3 Therapeutic Vaccines Price by Application (2015-2020)
5.2 Therapeutic Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Therapeutic Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Therapeutic Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Therapeutic Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Therapeutic Vaccines by Country
6.1.1 North America Therapeutic Vaccines Sales by Country
6.1.2 North America Therapeutic Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Therapeutic Vaccines Market Facts & Figures by Type
6.3 North America Therapeutic Vaccines Market Facts & Figures by Application

7 Europe
7.1 Europe Therapeutic Vaccines by Country
7.1.1 Europe Therapeutic Vaccines Sales by Country
7.1.2 Europe Therapeutic Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Vaccines Market Facts & Figures by Type
7.3 Europe Therapeutic Vaccines Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Therapeutic Vaccines by Region
8.1.1 Asia Pacific Therapeutic Vaccines Sales by Region
8.1.2 Asia Pacific Therapeutic Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Application

9 Latin America
9.1 Latin America Therapeutic Vaccines by Country
9.1.1 Latin America Therapeutic Vaccines Sales by Country
9.1.2 Latin America Therapeutic Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Therapeutic Vaccines Market Facts & Figures by Type
9.3 Central & South America Therapeutic Vaccines Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Vaccines by Country
10.1.1 Middle East and Africa Therapeutic Vaccines Sales by Country
10.1.2 Middle East and Africa Therapeutic Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Application

11 Company Profiles
11.1 Northeast Biotherapeutics
11.1.1 Northeast Biotherapeutics Corporation Information
11.1.2 Northeast Biotherapeutics Description and Business Overview
11.1.3 Northeast Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
11.1.5 Northeast Biotherapeutics Related Developments
11.2 Agenus
11.2.1 Agenus Corporation Information
11.2.2 Agenus Description and Business Overview
11.2.3 Agenus Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Agenus Therapeutic Vaccines Products Offered
11.2.5 Agenus Related Developments
11.3 Vaccinogen Inc
11.3.1 Vaccinogen Inc Corporation Information
11.3.2 Vaccinogen Inc Description and Business Overview
11.3.3 Vaccinogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Vaccinogen Inc Therapeutic Vaccines Products Offered
11.3.5 Vaccinogen Inc Related Developments
11.4 CIMAB S.A
11.4.1 CIMAB S.A Corporation Information
11.4.2 CIMAB S.A Description and Business Overview
11.4.3 CIMAB S.A Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CIMAB S.A Therapeutic Vaccines Products Offered
11.4.5 CIMAB S.A Related Developments
11.5 Dendreon
11.5.1 Dendreon Corporation Information
11.5.2 Dendreon Description and Business Overview
11.5.3 Dendreon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dendreon Therapeutic Vaccines Products Offered
11.5.5 Dendreon Related Developments
11.6 Corixa
11.6.1 Corixa Corporation Information
11.6.2 Corixa Description and Business Overview
11.6.3 Corixa Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Corixa Therapeutic Vaccines Products Offered
11.6.5 Corixa Related Developments
11.7 AVAX Technologies
11.7.1 AVAX Technologies Corporation Information
11.7.2 AVAX Technologies Description and Business Overview
11.7.3 AVAX Technologies Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AVAX Technologies Therapeutic Vaccines Products Offered
11.7.5 AVAX Technologies Related Developments
11.1 Northeast Biotherapeutics
11.1.1 Northeast Biotherapeutics Corporation Information
11.1.2 Northeast Biotherapeutics Description and Business Overview
11.1.3 Northeast Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
11.1.5 Northeast Biotherapeutics Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Therapeutic Vaccines Market Estimates and Projections by Region
12.1.1 Global Therapeutic Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Therapeutic Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Therapeutic Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Therapeutic Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Therapeutic Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Therapeutic Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Therapeutic Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Therapeutic Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Therapeutic Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Therapeutic Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Therapeutic Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Therapeutic Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Therapeutic Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Therapeutic Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Therapeutic Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer